Katayama, Ryohei <br/><br/>
Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers.  [electronic resource] 

 -  Science translational medicine  Feb 2012 
 - 120ra17 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1946-6242 
<br/><br/><label>Standard No.: </label>10.1126/scitranslmed.3003316  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anaplastic Lymphoma Kinase<br/>Cell Line, Tumor<br/>Crizotinib<br/>Drug Resistance, Neoplasm--genetics<br/>Humans<br/>Immunoblotting<br/>Immunohistochemistry<br/>In Situ Hybridization, Fluorescence<br/>Lung Neoplasms--drug therapy<br/>Mutation<br/>Polymerase Chain Reaction<br/>Protein Kinase Inhibitors--therapeutic use<br/>Pyrazoles--therapeutic use<br/>Pyridines--therapeutic use<br/>Receptor Protein-Tyrosine Kinases--genetics